BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Retina
,
Avian flu virus
,
Doxorubicin
,
rs3825942
,
PTEN
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ets-2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Spleen
Basophil of peripheral blood
Lung
Aorta
Hematopoietic stem cell of bone marrow
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease …
Suppression of USP7 negatively regulates the stability of ETS proto-oncogene 2 protein.
ETS2 alleviates acute-on-chronic liver failure by suppressing excessive inflammation.
ETS2 promotes cardiomyocyte apoptosis and autophagy in heart failure by regulating lncRNA TUG1/miR-1…
Ets-2 deletion in myeloid cells attenuates IL-1α-mediated inflammatory disease caused by a Ptpn6 poi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET)…
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma
ETE Interventions in the Dental Setting
Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Pat…
ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ